JPRN-UMIN000024312已完成未知
Studies of efficacy and safety of the combined use of febuxostat and inosine for patients with Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis or multiple sclerosis, and changes of blood and urine purine compounds. - Effect of febuxostat and inosine on CNS diseases
Tsukuba International Clinical Pharmacology Clinic0 个研究点目标入组 12 人开始时间: 2017年5月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Subjects taking azathioprine or mercaptopurine 2.Subject who has or had renal function disorder. 3.Subject with a history of gout, hyperuricemia or urolithiasis. 4.Subject who has a history of renal disorder. 5.Subject who has or had hypersensitivity, idiosyncracy (allergy) to drug. 6.Subject who was judged not to be appropriate by the principal investigator or sub investigators by other reasons.
研究者
相似试验
已完成
不适用
Studies of efficacy and safety of the combined use of febuxostat and inosine for patients with glucose intolerance, and changes of blood and urine purine compounds.JPRN-UMIN000024316Tsukuba International Clinical Pharmacology Clinic5
招募中
2 期
Evaluation of the safety and efficacy of combination of neostigmine and ketorolac added to reduced local anesthetic mixture dose through medial canthus injection in vitrectomy surgeryAnaesthesiaPACTR202204650206424Research institute of Ophthalmology50
已完成
4 期
Evaluation on efficacy and safety of a combination therapy of rituximab with bendamustin in the patients with relapsed or resistnat low grade B-cell non-Hodgkin lymphomapatients with relapsed or resistant low grade B-cell non-Hodgkin lymphomaJPRN-UMIN000008638Hiroshima University26
招募中
不适用
The evaluation for safety and efficacy of combination therapy of adoptive immune-cell therapy with chemoradiotherapy for locally advanced esophageal cancerJPRN-UMIN000014099Gunma University20
已完成
不适用
The evaluation for safety and efficacy of combination therapy of adoptive immune-cell therapy with chemoradiotherapy for locally advanced esophageal cancerocally advanced esophageal cancerJPRN-UMIN000017350Gunma University6